Home » Chinese Healthcare Investors »

|| Chinese investors of ORI Capital invested $18 million in Boston firm Pillar Biosciences

ori-china-pillarHong Kong-based venture capital group ORI Healthcare Fund has announced investment of $18 million into Pillar Biosciences, a Boston-based cancer research firm.

Pillar Biosciences is developing technologies and products for cancer diagnostics driven by next-generation sequencing (NGS). ORI Fund is a $200 million venture capital fund focused on investing in the healthcare industry globally. The fund is founded by Ms. Simone Hong Fang Song, former investment banker and head of China Healthcare at Goldman Sachs.

To see a list of investors from China similar to ORI Healthcare Fund, check the Chinese Investors Directory.

More details follows:

Previous Post: Chinese investors acquired the 134-year-old Chicago Stock Exchange
Next Post: Chinese investors acquired US printer manufacturer Lexmark for $3.6 billion

More from Chinese Healthcare Investors ...

  Chinese firm invested $12 million in UK company Blueberry Therapeutics

  Chinese investors acquired SciClone Pharmaceuticals for $605 million

  Chinese firm acquired Canada Iovate Health for $730 million

  Chinese investors acquired Australian vitamin maker Vitaco for $239 million

  Chinese investors of ORI Capital invested $18 million in Boston firm Pillar Biosciences

  Chinese investors of Citic acquired stake at Singapore medical firm for $817 million

  Chinese Hepalink acquired US Cytovance Biologics for $205 million

  Chinese investors acquired stake at Israeli biotech firm for $3 million

  Chinese investors of LongTec invested $10 million in RealView Imaging

  Chinese Decheng Capital and consortium invested $120 million in California genetics firm

| About Us

SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.

|Subscribe to mailing list

Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2024     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn

Powered by Insightice